Description: Zhongzhu Healthcare Holding Co., Ltd engages in the pharmaceuticals business in China. It offers ophthalmology drugs; and eye drops, acyclovir dispersible tablets, and gatifloxacin tablets. The company researches and develops drugs, such as Genistein capsule for the treatment of postmenopausal osteoporosis; and motherwort, a gynecological drug. Further, it offers medical instruments, including radiation therapy, hyperthermia, phototherapy, and ultrasound diagnosis, as well as develops imaging breast tumor detection systems. Additionally, the company offers medical services. It also engages in the real estate development and financial leasing business. The company was formerly known as Zhongzhu Holding Co., Ltd. and changed its name to Zhongzhu Healthcare Holding Co., Ltd in June 2016. The company was founded in 1970 and is headquartered in Zhuhai, China.
Home Page: www.zz600568.com
Zhongzhu Building
Zhuhai,
China
Phone:
86 72 8640 2068
Officers
| Name | Title |
|---|---|
| Mr. Liang Tan | Chief Financial Officer |
| Mr. Pei Chao Si | Exec. VP |
| Mr. Bao Long Qiao | VP & Director |
Exchange: SHG
Country: CN : China
Currency: Renminbi (¥)
| GIC Sector: | Real Estate |
|---|---|
| GIC Group: | Real Estate |
| GIC Industry: | Real Estate Management & Development |
| GIC Sub-Industry: | Real Estate Development |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.1615 |
| Price-to-Sales TTM: | 7.345 |
| IPO Date: | 2001-04-23 |
| Fiscal Year End: | December |
| Full Time Employees: | 1286 |